Navigation Links
Recipient of Melanoma Drug in Development Celebrates Two Cancer-Free Years
Date:10/16/2007

KNOXVILLE, Tenn., Oct. 16 /PRNewswire/ -- When eighty-six-year-old Keith Hora went to see Dr. Peter Hersey, a medical oncologist and professor at the University of Newcastle in Australia, he was told he only had three to six months to live. Hora had been diagnosed with stage III melanoma, one of the most difficult to treat forms of cancer.

"Mr. Hora had multiple melanoma reoccurrences in the previously treated area of his face and nothing was helping him, including multiple surgeries to remove the tumors as well as radiation therapy," recalls Dr. Hersey, a fifteen-year member of the World Health Organization's committee on Melanoma. "His tumors kept returning."

Hora was included in a Phase 1 clinical trial of PV-10 conducted by Dr. Hersey. The trials were sponsored by Knoxville, TN-based Provectus Pharmaceuticals. PV-10 is a small molecule oncology agent being investigated by Provectus for treatment of melanoma and other focal forms of cancer.

"When it is injected into tumor tissue, the drug concentrates in the tumor at cytotoxic levels while quickly dissipating from healthy tissue," says Dr. Hersey. "This makes it safer and more effective than some other therapies."

Hora was treated in late 2005 and recalled getting the good news a few weeks later during an ultrasound follow-up that determined the tumors were shrinking. "After being cancer-free for two years, I feel like jumping over a moon," says Hora.

Provectus has begun the next round of testing intended to demonstrate definitively the efficacy of PV-10. The Phase 2 trial will treat up to eighty Stage III/IV melanoma patients at seven or more sites in Australia and the U.S. While PV-10 is currently undergoing clinical trials to treat melanoma and breast cancer, in pre-clinical testing the drug has been shown to kill many other types of cancer. Additional clinical testing for treatment of primary and metastatic liver cancers is expected to begin later this year or early in 200
'/>"/>

SOURCE Provectus Pharmaceuticals
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine technology :

1. New Anti-Rejection Medication 6-Month Results for Heart Transplant Recipients to Be Released at International Heart and Lung Transplant Meeting
2. IDM Pharma Presents Preliminary Results from Phase II UVIDEM Melanoma Vaccine Clinical Trial
3. Synta Presents Results for STA-4783 in Metastatic Melanoma Showing Improvement in Overall Survival
4. Data Demonstrated Metastatic Melanoma Response to Investigational Immunotherapy Ipilimumab
5. Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III Melanoma Demonstrated Significant and Sustained Impact on Relapse-Free Survival
6. Kosan Presents Preliminary Phase 2 Data Showing Antitumor Activity of Hsp90 Inhibitor Tanespimycin in Metastatic Melanoma at ASCO
7. SciClone and Sigma-Tau Report Thymalfasin Meets Primary Endpoint in Phase 2 Malignant Melanoma Trial
8. Inovio Biomedicals DNA Delivery Technology Shows Safety and Enhances Gene Expression & Tumor Responses in Interim Melanoma Clinical Study Results
9. Multiferon Shows Potent Activity in Preventing the Progression of Malignant Melanoma; Study to be Published
10. Positive Clinical Results for DG041 Lead Product Development Highlights at deCODE R&D Event
11. Pieris Progresses Development of its Proprietary Biotherapeutics Platform: Successful Demonstration of Dual Targeting With Duocalin(R) Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... -- Accuray Incorporated (Nasdaq: ARAY ), a global ... its president and chief executive officer, Euan S. Thomson, ... J.P. Morgan Healthcare Conference in San Francisco on Wednesday, ... ,, A live webcast of each presentation will ... the Company,s Web site at http://www.accuray.com . ...
(Date:12/16/2009)... DATATRAK International, Inc. (OTCQX: DATA), ... global eClinical solutions for the clinical trials ... version 9.0 eClinical Software. This release ... and service delivery and introduces two new ... the DATATRAK Learning Center(TM) and the DATATRAK ...
(Date:12/16/2009)... -- HealthWarehouse.com, Inc. (OTC Bulletin Board: HEWA) an online ... million in 12% per annum short term debt financing. ... initial drawdown of $500,000, with accrued interest and principal ... with accrued interest and principal repayable in one year ... cashflow positive for any calendar month prior to December ...
Breaking Medicine Technology:Accuray Incorporated to Present at 28th Annual J. P. Morgan Healthcare Conference 2DATATRAK's eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM) 2DATATRAK's eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM) 3DATATRAK's eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM) 4HealthWarehouse.com, Inc. Secures $1 Million in Debt Financing 2National Alliance for Hispanic Health Applauds Confirmation of Sonia Sotomayor as the Nations 111th Supreme Court Justice 53920 1Hill Rom Reports Third Quarter Financial Results 53916 1Hill Rom Reports Third Quarter Financial Results 53916 2Hill Rom Reports Third Quarter Financial Results 53916 3Hill Rom Reports Third Quarter Financial Results 53916 4Hill Rom Reports Third Quarter Financial Results 53916 5Hill Rom Reports Third Quarter Financial Results 53916 6Hill Rom Reports Third Quarter Financial Results 53916 7Hill Rom Reports Third Quarter Financial Results 53916 8Hill Rom Reports Third Quarter Financial Results 53916 9Hill Rom Reports Third Quarter Financial Results 53916 10Hill Rom Reports Third Quarter Financial Results 53916 11Hill Rom Reports Third Quarter Financial Results 53916 12Hill Rom Reports Third Quarter Financial Results 53916 13Hill Rom Reports Third Quarter Financial Results 53916 14Hill Rom Reports Third Quarter Financial Results 53916 15Hill Rom Reports Third Quarter Financial Results 53916 16Hill Rom Reports Third Quarter Financial Results 53916 17Hill Rom Reports Third Quarter Financial Results 53916 18AutoImmune Inc Reports 2009 Second Quarter Financial Results 13438 1AutoImmune Inc Reports 2009 Second Quarter Financial Results 13438 2AutoImmune Inc Reports 2009 Second Quarter Financial Results 13438 3AutoImmune Inc Reports 2009 Second Quarter Financial Results 13438 4AutoImmune Inc Reports 2009 Second Quarter Financial Results 13438 5
(Date:12/17/2009)... Dec. 17 The recently opened ... out in the community in full force this holiday ... on December 13th, benefiting the Arthritis Foundation, a non-profit ... arthritis. The event boasted 1,500 attendees, spotlighting LSI,s passion ... is a renowned, national fundraiser and a festive way ...
(Date:12/17/2009)... University of Jerusalem Kuvin Center for the Study ... $5 million grant from the Bill & Melinda ... Ethiopia. , The project will be led by ... the Institute of Medical Research Israel-Canada at the ... entitled ,Studies on the ecology and transmission dynamics ...
(Date:12/17/2009)... How Exercise Has Helped, Healed, and Preserved Good Health ... ... Racquet & Sportsclub Association (IHRSA) announced today that as part of ... all ages and abilities to make 2010 the year we unite ... America wherein regular daily exercise is highly valued and widely practiced. ...
(Date:12/17/2009)... to perform fill/finish of nimotuzumab , ... ... and CEO of Therapure Biopharma Inc. and David Allan, Chairman ... of an agreement under which Therapure Biopharma will provide aseptic ... licensed to YM’s majority-owned Canadian subsidiary, CIMYM BioSciences Inc., by ...
(Date:12/17/2009)... Abaxis, Inc. (Nasdaq: ABAX ), ... instruments and rapid tests for the medical, research ... entered the production animal diagnostics marketplace with its ... This is a USDA-licensed test for Avian Influenza ... ducks. The disposable, non-instrumented device, providing results in ...
Breaking Medicine News(10 mins):Health News:Laser Spine Institute (LSI) Supports Jingle Bell Run 2Health News:Hebrew U. receives $5 million for research on leishmaniasis in Ethiopia 2Health News:IHRSA's Campaign for a Healthier America Calls on All Americans to Curtail Health Care Costs in 2010 by Becoming Physically Active 2Health News:IHRSA's Campaign for a Healthier America Calls on All Americans to Curtail Health Care Costs in 2010 by Becoming Physically Active 3Health News:IHRSA's Campaign for a Healthier America Calls on All Americans to Curtail Health Care Costs in 2010 by Becoming Physically Active 4Health News:IHRSA's Campaign for a Healthier America Calls on All Americans to Curtail Health Care Costs in 2010 by Becoming Physically Active 5Health News:Therapure Biopharma Inc. and YM BioSciences Inc. Announce Partnership 2Health News:Therapure Biopharma Inc. and YM BioSciences Inc. Announce Partnership 3Health News:Therapure Biopharma Inc. and YM BioSciences Inc. Announce Partnership 4Health News:ABAXIS(R) Announces Exclusive Worldwide OEM Agreement for a Lateral Flow Avian Influenza Antigen Test Kit 2Health News:ABAXIS(R) Announces Exclusive Worldwide OEM Agreement for a Lateral Flow Avian Influenza Antigen Test Kit 3Health News:ABAXIS(R) Announces Exclusive Worldwide OEM Agreement for a Lateral Flow Avian Influenza Antigen Test Kit 4
... Mich., Oct. 3 WHNN radio personality,Bob Hughes, a well-known ... Mobile Care Hearing which is moving to Saginaw this,month. ... Rock ,n,Roll music and the quality of my life has ... devices at Mobile Care Hearing,",says Hughes. "I am really enjoying ...
... 3 Pink tags will be on display,throughout Food ... as the,supermarket chain partners with vendors and suppliers to ... the month, pink tags can be found on shelves ... Nevada and Foods Co stores in,Central and Northern California ...
... 3 President Bush,s veto today,of a bill ... of,children from families with low incomes creates a ... says Oral Health America, a national,advocacy organization. President ... children eligible for coverage through a,bipartisan, bicameral agreement ...
... AIRES, Argentina, October 3, 2007 The first reported ... more than two-thirds of patients with moderate to severe ... achieved at least a 75 percent reduction in psoriasis ... as measured by the Psoriasis Area and Severity Index ...
... The Stop & Shop Supermarket,Company, Giant Food and General ... for the Cure with the Pink for the Cure Program. ... Shop/Giant,Consumer Advisor Andrea Astrachan, "and by purchasing ,Pink for the ... the fight against,breast cancer and help us donate to this ...
... Nurses,Association/National Nurses Organizing Committee today condemned President,Bush,s veto of ... "Listening to the overheated rhetoric coming out of ... gone but his legacy lives on," said Zenei,Cortez, RN, ... for his recent claims that legislators who passed the ...
Other Medicine News:Health News:WHNN's Bob Hughes Fitted With Hearing Aids by Mobile Care Hearing Clinic Now Serving Saginaw Area 2Health News:Food 4 Less/Foods Co 'Pink Tag' Campaign to Raise $150,000 for Breast Cancer Awareness in October 2Health News:SCHIP Veto a Big Cavity for Children's Oral Healthcare, Advocates Say 2Health News:Promising Phase 3 trial results show biologic therapy ustekinumab significantly improved psoriasis 2Health News:Promising Phase 3 trial results show biologic therapy ustekinumab significantly improved psoriasis 3Health News:Promising Phase 3 trial results show biologic therapy ustekinumab significantly improved psoriasis 4Health News:Stop & Shop and Giant Food Join General Mills in Pink for the Cure 2Health News:California Nurses Association Blasts Bush for Veto on Children's Health 2
... MJS anatomic knee system ... durability, minimize polyethylene wear ... to minimize contact stress ... to achieve a well ...
The Balanced Knee™ system provides instrumentation designed to achieve proper tissue balancing and alignment with user-friendly instrumentation that provides reproducible results....
... a cruciate sparing version which provides ... both resurfacing and inset patellas. Precision ... and fit with tibial articular surface ... cutting guide peg locations provide easy ...
... a femoral option and tibial insert which provides ... 60 degrees of flexion to induce a smooth ... degrees of flexion. Femoral component comes in a ... The constrained tibial insert in conjunction with the ...
Medicine Products: